Clinical impact of use of different PSA assays in prostate cancer screening

被引:0
|
作者
Maciej, Kwiatkowski
Daniel, Seiler
Brigitte, Arndt
Joel, Gregorin
Andreas, Huber [1 ]
Franz, Recker
机构
[1] Kantonsspital, Ctr Lab Med, Aarau, Switzerland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:118 / 118
页数:1
相关论文
共 50 条
  • [41] New recommendations for prostate cancer screening with PSA
    Julia-Romero, C.
    Rechi-Sierra, K.
    Juan-Escudero, J. U.
    MEDICINA DE FAMILIA-SEMERGEN, 2021, 47 (05): : 342 - 347
  • [42] PSA screening and prostate cancer risk reduction
    Andriole, Gerry L., Jr.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2012, 30 (06) : 936 - 937
  • [43] PSA screening for prostate cancer:: The current controversy
    de Koning, HJ
    Schröder, FH
    ANNALS OF ONCOLOGY, 1998, 9 (12) : 1293 - 1296
  • [44] The first artificial neural network for five different PSA-assays in prostate cancer diagnostics
    Stephan, Carsten
    Cammann, Henning
    Miller, Kurt
    Deger, Serdar
    Lein, Michael
    Jung, Klaus
    JOURNAL OF UROLOGY, 2008, 179 (04): : 603 - 603
  • [45] Use and Assessment of PSA in Prostate Cancer
    Gjertson, Carl K.
    Albertsen, Peter C.
    MEDICAL CLINICS OF NORTH AMERICA, 2011, 95 (01) : 191 - +
  • [46] Prostate cancer and prostate specific antigen (PSA) screening in Austria
    Vutuc, C
    Schernhammer, ES
    Haidinger, G
    Waldhör, T
    WIENER KLINISCHE WOCHENSCHRIFT, 2005, 117 (13-14) : 457 - 461
  • [47] Prostate cancer and prostate-specific antigen (PSA) screening in AustriaProstatakarzinom und PSA-Screening in Österreich
    Christian Vutuc
    Eva S. Schernhammer
    Gerald Haidinger
    Thomas Waldhör
    Wiener klinische Wochenschrift, 2005, 117 : 457 - 461
  • [48] COMBINED ROLE OF SERUM ASSAYS OF PSA-IGM AND PSA FOR THE DIAGNOSIS OF PROSTATE CANCER
    Zani, Danilo
    Costa, Silvia
    Petteno, Alberto
    Simeone, Claudio
    Cunico, Sergio Cosciani
    Leon, Antonette
    Gion, Massimo
    Fassina, Giorgio
    Beneduce, Luca
    ANTICANCER RESEARCH, 2010, 30 (04) : 1496 - 1497
  • [49] IMPACT OF EXPOSURE RATE OF PROSTATE SPECIFIC ANTIGEN (PSA) SCREENING ON INCIDENCE OF METASTATIC PROSTATE CANCER IN JAPAN
    Ito, Kazuto
    Yamamoto, Takumi
    Miyakubo, Mai
    Takechi, Hiroyuki
    Ohi, Masaru
    Suzuki, Kazuhiro
    JOURNAL OF UROLOGY, 2009, 181 (04): : 798 - 799
  • [50] Estimation of treatment benefits when PSA screening for prostate cancer is discontinued at different ages
    Ross, KS
    Guess, HA
    Carter, HB
    UROLOGY, 2005, 66 (05) : 1038 - 1042